Bizarre Patents
Behavior Modification Wristwatch
A wristwatch including a watch band and a watch body having an octagon shaped perimeter and being red in color and having the word STOP thereon to resemble a stop sign.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 4859707 | Sulfur-substituted phenylacetamides This invention relates to sulfur-substituted phenylacetamides of the formula ##STR1## wherein R1, R2 and R3 may be the same or different and are H or CH3 ; R4 is SR5, ##STR2## ... | 08/22/1989 |
| 4722726 | Method and apparatus for iontophoretic drug delivery A device for iontophoretic delivery of active ingredient to a patient, that includes an electrode, a first cavity for holding a solution of at least partially active ingredient in ionizing form to be delivered to a patient, a member for maintaining a solu... | 02/02/1988 |
| 4708867 | Minipellets A minipellet dosage form of prednisone or prednisolone, resistant to attack by saliva but readily dissolvable in gastric juice, which comprises a mixture of prednisone or prednisolone and polyvinylpyrrolidone coated onto a nonpareil seed, and further coat... | 11/24/1987 |
| 4689213 | Method and composition for treating bronchospastic airway diseases Bronchospastic diseases characterized by airway hyperreactivity are treated by administration of the calcium channel blocker gallopamil. Unlike other calcium channel blockers, the effective dose of gallopamil is small enough that undesirable side effects ... | 08/25/1987 |
| 4679555 | Method and apparatus for intrapulmonary delivery of heparin An apparatus comprised of a canister having a valved opening thereon and containing, under pressure, heparin and a low boiling point propellant is disclosed. The valved opening can be activated to release a metered dose of aerosolized heparin to a patient... | 07/14/1987 |
| 4639455 | Means of aiding in the prevention of sudden infant death syndrome A means of aiding in the prevention of Sudden Infant Death Syndrome (SIDS) is disclosed. The means comprises administering a pharmaceutically effective amount of the drug 6-methylene-6-desoxy-N-cylopryplymethyl-14-hydroxydihydronormorphone to an infa... | 01/27/1987 |
| 4634587 | Sustained release quinidine dosage form A sustained release quindine dosage form is made from a plurality of pellets. Each pellet includes a quinidine-containing coating over a nonpareil seed, with a further coating of about 5 to about 15% by weight of a mixture of about 1.5 to about 9 parts by... | 01/06/1987 |
| 4594356 | Method for inducing mydriasis in animals A method of inducing short-term pupil diameter enlargement and reducing intraocular pressure in animals without significant systemic effects is disclosed. There is provided a site-specific chemical delivery method for topically applying to the eye of an a... | 06/10/1986 |
| 4587118 | Dry sustained release theophylline oral formulation A dry sustained release oral dosage formulation of theophylline and a method of orally administering theophylline is disclosed. The oral formulation is comprised of a capsule which includes upper and lower parts which are connectible and easily separable ... | 05/06/1986 |
| 4585452 | Transdermal systemic dosage forms Sustained release dosage forms that provide transdermal delivery of drugs utilizing the skin as the rate controlling membrane for the drugs. Methods for producing the dosage forms are also disclosed. The dosage forms are laminates produced by heating a la... | 04/29/1986 |
| 4579731 | Polymeric diffusion burn matrix and method of use A protective skin matrix is provided which is particularly suited for the protection of burned or wounded patients. The matrix may be either cured, applied in sheets, or painted or sprayed directly onto the burned or wounded patient. The protective skin m... | 04/01/1986 |
| 4567185 | Endorphin blockage A method of permitting restful sleep at high altitudes is disclosed involving administration to a patient susceptible to Cheyne-Stokes respiration of a pharmaceutically acceptable amount of an endorphin-blocking compound capable of blocking the action of ... | 01/28/1986 |
| 4562206 | Orally effective inotropic compounds A method for increasing cardiac contractility in a warm-blooded animal suffering from acutely depressed cardiac contractility which comprises administering to said animal an effective amount of a compound of the formula ##STR1## wherein R is hyd... | 12/31/1985 |
| 4556678 | Sustained release propranolol tablet A method of providing a patient suffering from cardiac arrhythmia with a sustained dosage of propranolol over a prolonged period of time comprises orally administering to the patient a tablet consisting essentially of a therapeutically effective amount of... | 12/03/1985 |
| 4555399 | Aspirin tablet A tablet, which readily disintegrates in gastric fluid to give aspirin crystals coated with a polymeric film preventing the aspirin crystals from contacting the stomach wall but not preventing access of gastric fluid to the aspirin contained within the po... | 11/26/1985 |
| 4542013 | Trinitroglycerol sustained release vehicles and preparation therefrom A trinitroglycerol-containing substantially disaccharide-free polymeric diffusion matrix is provided for the transdermal systemic delivery of trinitroglycerol through the skin of a patient. The polymeric diffusion matrix contains sufficient trinitroglycer... | 09/17/1985 |
| 4535157 | Process for making 6-desoxy-6-methylenenaloxone and 6-desoxy-6-methylenenaltrexone An improved Wittig reaction for making 6-desoxy-6-methylenenaloxone and 6-desoxy-6-methylenenaltrexone from naloxone and naltrexone utilizing an alkoxide base in an ethereal solvent.... | 08/13/1985 |
| 4511570 | Senile dementia treatment A method is provided for orally treating a patient suffering from senile dementia which comprises the periodic oral delivery of a pharmaceutically effective amount of 6-methylene-6-desoxy-N-cyclopropylmethyl-14-hydroxydihydronormorphone to said patie... | 04/16/1985 |
| 4508702 | Sustained release aspirin A sustained release aspirin dosage form permits the continuous delivery of aspirin into the gastrointestinal tract for a period of at least eight hours. The sustained release aspirin dosage form comprises a plurality of polymerically coated aspirin crysta... | 04/02/1985 |
| 4496570 | 4,5댞poxymorphinan -6-spiro-2'-(4'-carboxy,1',3'-thiazolidine)derivatives Compounds the structural formula ##STR1## or their pharmaceutically acceptable salts, wherein X is H or CH3, Z is NH2 or OR6, R1 is a C1-8 alkyl, C3-6 -cycloalkylmethyl, or phenyl-C | 01/29/1985 |
| 4492685 | Protective skin matrix A protective skin matrix is provided which is particularly suited for the protection of burned or wounded patients. The matrix may be either cured, applied in sheets, or painted or sprayed directly onto the burned or wounded patient. The protective skin m... | 01/08/1985 |
| 4484577 | Drug delivery method and inhalation device therefor A method and an apparatus for administering a drug through a breathing passage for absorption on the mucous tissue of a patient includes introducing an aerosol of the drug into an expanded bag and bidirectional channel for communicating the drug with the ... | 11/27/1984 |
| 4483860 | Hyperkinetic child treatment agent A method of orally treating a child having a tendency to be overactive to the extent of requiring an external control which comprises orally administering to said child a pharmaceutically effective amount of (-)-17-(cyclopropylmethyl)-4,5-alpha-epoxy-3,14... | 11/20/1984 |
| 4483854 | Systemic treatment of psoriasis using certain salicylates Psoriasis is systemically treated by the administration of a salicylate which is capable of inhibiting the endogenous lipoxygenase present in psoriatic plaque fluid without the inhibition of the cyclooxygenase enzyme.... | 11/20/1984 |
| 4482533 | Polymeric diffusion matrix containing propranolol A self-supporting polymeric diffusion matrix provides for the sustained release of propranolol in order to deliver said propranolol to a patient. The matrix comprises from about 1 to about 60% by weight of a polar plasticizer, from about 5 to about 20% by... | 11/13/1984 |
| 4472372 | Polymeric diffusion matrix containing chlorpheniramine maleate There is disclosed a polymeric diffusion matrix for the sustained release of chlorpheniramine maleate by transdermal delivery to a patient wherein the matrix comprises a polar plasticizer, polyvinylalcohol, polyvinylpyrrolidone, and a pharmaceutically eff... | 09/18/1984 |
| 4470962 | Polymeric diffusion matrix A polymeric diffusion matrix is provided comprising from about 2 to about 60% glycerol, from about 2 to about 15% polyvinylalcohol, from about 2 to about 10% water soluble polymer with hydration sites which in combination with the remaining ingredients yi... | 09/11/1984 |
| 4466953 | Polymeric diffusion matrix A polymeric diffusion matrix is provided comprising from about 2 to about 60% glycerol, from about 2 to about 15% polyvinylalcohol, from about 2 to about 10% water soluble polymer with hydration sites which in combination with the remaining ingredients yi... | 08/21/1984 |
| 4460562 | Polymeric diffusion matrix containing propranolol A self-supporting polymeric diffusion matrix provides for the sustained release of propranolol in order to deliver the propranolol to a patient. The matrix comprises from about 1 to about 60% of a polar plasticizer, from about 6 to about 30% by weight pol... | 07/17/1984 |
| 4456587 | Pheromone delivery system This invention provides an aqueous mixture capable of being sprayed onto the leaves of plants and being cured in situ on the leaves. The thus cured mixture comprises polyvinylalcohol and polyvinylpyrrolidone. The cured mixture is capable of the sustained ... | 06/26/1984 |
| 4454142 | Hyperkinetic child treatment agent Provided is a method of orally treating a child having a tendency to be overactive to the extent of requiring an external control which comprises orally administering to said child a pharmaceutically effective amount of 6-methylene-6-desoxy-N-cyclopropylm... | 06/12/1984 |
| 4442941 | Anti-spilling drug capsule A capsule for housing pellets is disclosed having two members, the first with a raised portion and the second with a connecting groove and an annular groove for interconnection with the raised portion to secure the two members together.... | 04/17/1984 |
| 4438139 | Polymeric diffusion matrix containing estrogens A polymeric diffusion matrix for the sustained release, intravaginal administration of an estrogen is provided. The matrix consists of polyvinylalcohol, polyvinylpyrrolidone and a polar plasticizer.... | 03/20/1984 |
| 4432965 | Quinidine sustained release dosage formulation A sustained release oral dosage form is provided comprising a tablet core containing a pharmaceutically effective amount of quinidine. The tablet core is coated with a sustained release polymeric coating which contains about 5 to about 20 percent by weigh... | 02/21/1984 |
| 4428925 | Sustained release glycerol trinitrate Glycerol trinitrate is delivered orally in a sustained release dosage form. The dosage form is for oral administration and comprises a core containing the drug and a coating of an expandable lattice, said expandable lattice permitting the passage of water... | 01/31/1984 |
| 4428926 | Sustained release propranolol system Propranolol is delivered orally in a sustained release dosage form. The dosage form is for oral administration and comprises a core containing the drug and a coating of an expandable lattice, said expandable lattice permitting the passage of water thereth... | 01/31/1984 |
| 4425336 | 3,4-Dih ydroxy-N-[3-(4-dihydroxyphenyl)-1-methyl-n-propyl]-beta-phenethylamine cyclodextrin complexes Cardiac contractility agents are provided which are 3,4-dihydroxy-N-[3-(4-hydroxyphenyl)-1-methyl-n-propyl]-beta-phenethylamin e cyclodextrin complexes.... | 01/10/1984 |
| 4424209 | 3,4-Di -isobutyryloxy-N-[3-(4-isobutyryloxyphenyl)-1-methyl-n-propyl]-beta-phene thylamine cyclodextrin complexes Cardiac contractility agents are provided which are 3,4-di-isobutyryloxy-N-[3-(4-isobutyryloxyphenyl)-1-methyl-n-propyl]-beta- phenethylamine, preferably orally deliverable forms which are cyclodextrin complexes.... | 01/03/1984 |
| 4321252 | Polymeric diffusion matrix containing ester derivatives of estradiol There is disclosed a polymeric diffusion matrix for the sustained release of an estradiol ester by delivery to a patient requiring uterine wall maintenance or other types of estrogen therapy wherein the matrix comprises a polar plasticizer, polyvinylalcoh... | 03/23/1982 |
| 4297995 | Bandage containing attachment post A bandage is disclosed comprising a lower portion and a matrix. The lower portion has an upper surface, a base plate on the upper surface, and a post extending from the surface of the base plate. The matrix is attached to the lower portion by means of a h... | 11/03/1981 |
